| 1 |
32741197 | Inpatient Initiation of Sacubitril/Valsartan. | 2021 Apr |
2 |
| 2 |
33522140 | Acute pulmonary pressure change after transition to sacubitril/valsartan in patients with heart failure reduced ejection fraction. | 2021 Apr |
1 |
| 3 |
33847047 | Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics. | 2021 Jun |
1 |
| 4 |
32303468 | Cost-Effectiveness of Switching Patients With Heart Failure and Reduced Ejection Fraction to Sacubitril/Valsartan: The Australian Perspective. | 2020 Sep |
1 |
| 5 |
32327307 | Impact of Patient and Model of Care Factors on Titration and Tolerability of Sacubitril/Valsartan: An Early Australian Real-World Experience. | 2020 Nov |
1 |
| 6 |
32546023 | New pharmacotherapy for heart failure with reduced ejection fraction. | 2020 Jul |
1 |
| 7 |
33004114 | Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF. | 2020 Oct |
1 |
| 8 |
31240976 | Effects of the Angiotensin-Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta-Analysis. | 2019 Jul 2 |
1 |
| 9 |
31521679 | Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection Fraction. | 2019 Nov |
1 |
| 10 |
29369824 | Was the Enalapril Dose Too Low in the PARADIGM-HF Trial? | 2018 Jul/Aug |
3 |
| 11 |
30441998 | Pharmacological therapy for chronic heart failure. | Fall 2018 |
1 |
| 12 |
28176581 | Correction. | 2017 Feb 8 |
2 |
| 13 |
28720639 | Angioedema Spotlight: A Closer Examination of Sacubitril/Valsartan Safety Results. | 2017 Jul-Aug |
1 |
| 14 |
26642078 | Sacubitril/valsartan (LCZ696) for the treatment of heart failure. | 2016 |
1 |
| 15 |
26873036 | Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure. | 2016 Apr |
1 |
| 16 |
26873495 | Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction. | 2016 Mar |
1 |
| 17 |
27638852 | The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan. | 2016 Jul |
4 |
| 18 |
27924184 | Revealed Opportunism: How Physicians "Game" Prior Authorization Protocols Until They Are Rescinded. | 2016 Sep |
1 |
| 19 |
28905031 | Update of treatment of heart failure with reduction of left ventricular ejection fraction. | 2016 |
1 |
| 20 |
21142805 | A drug safety evaluation of valsartan. | 2011 Mar |
1 |
| 21 |
21303424 | Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms. | 2011 Jul |
1 |
| 22 |
19192258 | An economic evaluation of valsartan for post-MI patients in the UK who are not suitable for treatment with ACE inhibitors. | 2009 Jun |
3 |
| 23 |
19911855 | Valsartan: more than a decade of experience. | 2009 |
2 |
| 24 |
19929036 | The cost effectiveness and cost utility of valsartan in chronic heart failure therapy in Italy: a probabilistic markov model. | 2009 |
2 |
| 25 |
19205092 | Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination. | 2008 Dec |
1 |
| 26 |
17061457 | [Angiotensin receptor blockers and cardiac rhythm disorders]. | 2006 Jul-Aug |
2 |
| 27 |
15686787 | Valsartan versus ACE inhibition after bare metal stent implantation--results of the VALVACE trial. | 2005 Feb 15 |
2 |
| 28 |
15687480 | Valsartan in chronic heart failure. | 2005 Mar |
4 |
| 29 |
15857354 | A review of the current evidence for the use of angiotensin-receptor blockers in chronic heart failure. | 2005 May |
1 |
| 30 |
16117995 | Use of valsartan for the treatment of heart-failure patients not receiving ACE inhibitors: a budget impact analysis. | 2005 Jun |
1 |
| 31 |
16129801 | C-reactive protein in heart failure: prognostic value and the effect of valsartan. | 2005 Sep 6 |
1 |
| 32 |
16259523 | ACE inhibitors in heart failure: what more do we need to know? | 2005 |
1 |
| 33 |
16380005 | Valsartan reduces morbidity in people with heart failure receiving a low dose of ACE inhibitor and no beta-blocker. Commentary. | 2005 Jun |
1 |
| 34 |
19804097 | Valsartan: the past, present and future. | 2005 Sep |
1 |
| 35 |
15215801 | Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). | 2004 Jul |
1 |
| 36 |
12630586 | Therapeutic role of angiotensin II receptor blockers in the treatment of heart failure. | 2003 Mar |
1 |
| 37 |
12729848 | Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations. | 2003 May 8 |
1 |
| 38 |
12791814 | Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure. | 2003 Jun |
1 |
| 39 |
12918546 | New developments in the management of heart failure: a review of the literature in 2002. | 2003 May |
1 |
| 40 |
11835907 | From the HOPE to the ONTARGET and the TRANSCEND studies: challenges in improving prognosis. | 2002 Jan 24 |
1 |
| 41 |
11899501 | [Clinical study of the month. Effects of valsartan in chronic heart failure: the VAL-HeFT study]. | 2002 Jan |
2 |
| 42 |
12016625 | Comment--Val-HeFT and angiotensin-receptor blockers in perspective: A tale of the blind man and the elephant. | 2002 Apr |
3 |
| 43 |
12093312 | Angiotensin II receptor antagonists in chronic heart failure: where do they fit? | 2002 |
1 |
| 44 |
12392830 | Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors. | 2002 Oct 16 |
2 |
| 45 |
12417542 | Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT). | 2002 Nov 5 |
1 |
| 46 |
12512757 | Renin-angiotensin system inhibition: how much is too much of a good thing? | 2002 Dec |
1 |
| 47 |
14727972 | Valsartan: in chronic heart failure. | 2002 |
3 |
| 48 |
11676153 | [Review of randomized trials of angiotensin receptor blockers in the treatment of patients with congestive heart failure]. | 2001 Oct |
1 |
| 49 |
11759645 | A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. | 2001 Dec 6 |
2 |
| 50 |
10618583 | Cardiac protection: evolving role of angiotensin receptor blockers. | 2000 Jan |
1 |